Clinical Significance of miR-149 in the Survival of Patients with Laryngeal Squamous Cell Carcinoma

Abstract EN

MicroRNAs (miRNAs) play critical roles in the progression of laryngeal cancer (LC).

In this study, we aimed to investigate whether miR-149 is associated with the prognosis of patients with LC.

A total of 97 laryngeal squamous cell carcinoma patients who underwent tumor resection were included in our follow-up study.

In vitro studies was performed in cancer cell line Hep-2 to explore the antitumor role of miR-149 in LC.

We found that the expression of miR-149 was significantly lower in tumor tissues, compared with vocal cord polyp tissues ( P < 0.05 ).

Kaplan-Meier analysis revealed that miR-149 expression status is significantly associated with survival duration (log rank test, P < 0.0 5 ), and multivariate Cox regression analysis revealed that patients with low miR-149 expression had shorter survival times compared with patients with high miR-149 expression.

In vitro studies revealed that the exogenous expression of miRNA-149 inhibits the proliferation of human Hep-2 cells and induces cell apoptosis.

Our study suggests that miR-149 expression in laryngeal squamous cell carcinoma tissues is critically associated with the prognosis of patients, and the ectopic expression of miR-149 in Hep-2 cells inhibits proliferation and cell cycle progression.